Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-08-27 22:29:45 - browse：37621

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Cherokee Nation medical school graduates its first class

WSS

HHS suspends federal funding for EcoHealth Alliance

To avoid data mishandling cases, universities eye AI and other tools

Ripples from Flovent's discontinuation is killing children with asthma

How digital tools helped lower hypertension in marginalized patients

Galapagos to make CAR

Abbott's new stent may help patients with peripheral artery disease

focus

Wikipedia

focus

Drug repurposing or repositioning? The language matters

The Readout: Gilead, Bernie Sanders, and other pharma news

Sports medicine is finally prioritizing gender equality

Boston hospital trains restaurant workers on naloxone for overdoses

Medicare proposal to cover medical devices draws a mixed reaction

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT reporters are Pulitzer Prize finalists for investigative reporting

Hollywood unions extend contract negotiations for actors

Gilead might be held responsible for not developing a drug

entertainment

Biogen Alzheimer’s drug launch off to slow start

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

The United States must get value

Cherokee Nation medical school graduates its first class

Abbott's new stent may help patients with peripheral artery disease

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Wikipedia

hotspot

leisure time

entertainment